Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations.
Monitoring of nitric oxide (NO) and nitrogen dioxide (NO2) is a prerequisite for the clinical use of NO. Chemiluminescence, the reference method, cannot be used as a routine in clinical practice in view of its cost and other restraints. This study was performed to evaluate a device using an electrochemical method (Polytrons NO and NO2, Dräger). Forty-nine simultaneous measurements of NO and various oxides of nitrogen (NOx) concentrations by the two apparatus were performed. NO measurements by means of these two methods are very well correlated (r = 0.96; p < 10(-5)). The mean difference according to the method of Bland and Altman was 2.8 +/- 1.7 ppm, with the limits of agreement at -0.6 and +6.2 ppm (confidence interval of 95%). There was also a good correlation between measurements of NO2 obtained via Polytrons and NOx via chemiluminescence (r = 0.84; p < 10(-5)). However, NO2 measurements obtained via Polytrons may be insufficient to exclude potential toxicity of NO2 due to the inability to detect measurements in the ppb-range. This study demonstrates that devices designed for industrial purposes (Polytrons NO and NO2, Dräger) can be used for clinical purposes.
Moutafis
M
M
Service d'Anesthésie, CMC Foch, Suresnes, France.
Hatahet
Z
Z
Castelain
M H
MH
Renaudin
M H
MH
Monnot
A
A
Fischler
M
M
D000280:Administration, Inhalation; D016903:Drug Monitoring / Q000295:instrumentation*; D004563:Electrochemistry; D006801:Humans; D008163:Luminescent Measurements; D009569:Nitric Oxide / Q000008:administration & dosage / Q000032:analysis*; D009585:Nitrogen Dioxide / Q000008:administration & dosage / Q000032:analysis*; D012015:Reference Standards; D012044:Regression Analysis
D009569:Nitric Oxide; D009585:Nitrogen Dioxide